Pediatricians have so much faith in a drug for treating neonatal hyperbilirubinemia that even though it hasn't been approved by the Food & Drug Administration yet, they are recommending its use in their just-released guidelines.
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.